Skip to content

Scarlet Fever

BASICS

  • Definition: A childhood disease characterized by fever, pharyngitis, and a "sandpaper" rash, caused by group A Ξ²-hemolytic Streptococcus pyogenes (GAS) producing erythrogenic toxin.
  • Incubation: 1–7 days; illness duration 4–10 days.
  • Key Features: Rash appears 24–48 hours after symptom onset, begins in groin/trunk/axillae, spreads to extremities, spares palms/soles. Strawberry tongue and circumoral pallor are classic.
  • Rash: Erythematous, blanchable, 1–2 mm papules, clears by end of week 1, followed by weeks of desquamation.

EPIDEMIOLOGY

  • Incidence: 15% of school-aged children, 4–10% of adults have an episode of GAS pharyngitis yearly.
  • Peak Age: 4–8 years (common 6–12 years), rare in >12 years.
  • Sex: Male = female.
  • Prevalence: 15–30% of pharyngitis cases in children due to GAS; <10% of children with GAS pharyngitis develop scarlet fever.
  • Seasonality: Winter/early spring.
  • Transmission: Airborne respiratory droplets, saliva, nasal secretions; rare foodborne outbreaks.

ETIOLOGY & PATHOPHYSIOLOGY

  • Pathogen: GAS producing erythrogenic toxin (types A, B, C).
  • Mechanism: Toxins damage capillaries (rash) and act as superantigens.
  • Immunity: Antitoxin antibodies prevent rash but not infection.
  • Primary Infection Sites: Usually tonsils, but also skin, surgical wounds, uterus.

RISK FACTORS

  • School-aged children, winter/early spring, contact with infected individuals, crowded conditions.

PREVENTION

  • Exclude afebrile children from school/daycare until 24h after starting antibiotics.
  • Symptomatic contacts should be tested and treated if positive.
  • Asymptomatic contacts do not require cultures/prophylaxis.

ASSOCIATED CONDITIONS

  • Suppurative: Pharyngitis, impetigo, otitis media, sinusitis, abscesses, pneumonia.
  • Nonsuppurative: Rheumatic fever, glomerulonephritis.

DIAGNOSIS

History

  • Prodrome: 1–2 days of sore throat, headache, myalgia, malaise, fever (>38Β°C), vomiting, abdominal pain.
  • Rash: Scarlatiniform, punctate, erythematous, appears after 24–48h, spreads rapidly.

Physical Exam

  • Oral: Beefy red tonsils/pharynx, palatal petechiae, white (early) then red strawberry tongue, circumoral pallor.
  • Rash: Scarlet, sandpaper texture, blanches, initially groin/axilla/trunk, spreads to extremities, spares palms/soles.
  • Other: Pastia lines (transverse red streaks at skin folds), flushed face, desquamation after 7–10 days (starts on face, then trunk/hands/feet), vesicles in severe cases.

Differential Diagnosis

  • Viral exanthems (measles, rubella, roseola, fifth disease), mono, mycoplasma, TSS, staphylococcal scalded-skin syndrome, Kawasaki, lupus, juvenile arthritis, drug rash, sunburn.

Diagnostic Tests

  • Rapid antigen detection test (RADT) / PCR: Confirm GAS. In children, negative RADT should be confirmed by throat culture. Positive RADT or PCR is diagnostic.
  • Throat culture: Gold standard for GAS (99% specificity, 90–97% sensitivity).
  • Modified Centor score: Clinical decision rule for likelihood of GAS pharyngitis.
  • Serologic tests: Not recommended for acute diagnosis.
  • CBC: May show leukocytosis.
  • Gram stain: Gram-positive cocci in chains.

TREATMENT

General Measures

  • Supportive: analgesics/antipyretics (acetaminophen/NSAIDs), throat lozenges, topical anesthetics.
  • Exclude aspirin in children (Reye syndrome risk).

Antibiotics

First Line

  • Penicillin V: 10 days (children <27 kg: 250 mg BID/TID; >27 kg/adults: 250 mg QID or 500 mg BID).
  • Benzathine penicillin G: Single IM dose (<27 kg: 600,000 U; >27 kg: 1.2 million U) for compliance issues.
  • Amoxicillin: 50 mg/kg (max 1,000 mg) once daily or 25 mg/kg (max 500 mg) BID for 10 days (preferred in children).

Second Line (Penicillin Allergy)

  • Type IV allergy: 1st-gen cephalosporins (cephalexin, cefadroxil).
  • Type I allergy: Macrolides (azithromycin, clarithromycin), clindamycin.
  • Avoid: Tetracyclines and sulfonamides.

Surgical

  • Tonsillectomy: For recurrent infections (>6 in 1 year).

ONGOING CARE

  • No follow-up cultures unless symptomatic.
  • Reinfection usually due to poor adherence or environmental re-exposure.
  • Children can return to school after 24h of antibiotics and afebrile.
  • Advise hygiene, hand-washing, not sharing utensils.

PATIENT EDUCATION

  • Full course of antibiotics is essential.
  • Delayed antibiotics (up to 10 days after symptoms start) still prevent rheumatic fever.
  • Rash is not dangerous; marker of GAS infection.

PROGNOSIS

  • Treatment shortens symptoms by 1–2 days, reduces complications and contagiousness.
  • Desquamation may last weeks.
  • Recurrent attacks possible (different toxin types).

COMPLICATIONS

  • Suppurative: Sinusitis, otitis, mastoiditis, cervical adenitis, abscesses, pneumonia, bacteremia, meningitis, septic arthritis, endocarditis, necrotizing fasciitis.
  • Nonsuppurative: Rheumatic fever (preventable if antibiotics within 10 days), glomerulonephritis (not clearly prevented by antibiotics), toxic shock, PANDAS, poststreptococcal reactive arthritis.
  • Other: Nail grooves, telogen effluvium (hair loss), scarlet fever may rarely cause severe complications.

ICD-10

  • A38.9 Scarlet fever, uncomplicated
  • J02.0 Streptococcal pharyngitis
  • A38.0 Scarlet fever with otitis media

CLINICAL PEARLS

  • Suspect scarlet fever in children with fever and exanthematous rash.
  • Classic findings: strawberry tongue, circumoral pallor, coarse sandpaper rash, Pastia lines.
  • Penicillin (or amoxicillin in children) remains the treatment of choice.
  • Use Centor score and rapid testing to guide diagnosis.
  • Desquamation after 7–10 days is characteristic and can last weeks.